Table 2.
Summary of postherpetic neuralgia patients.
| No. | Gender | Age | Spinal cord level | Duration from onset to pain clinic | Previous treatment | Follow-up |
|---|---|---|---|---|---|---|
| 1 | M | 56 | C8-T1 | 9 m | Vitamin B6, Vitamin B12 | 1 |
| 2 | F | 82 | T levels | Not known | No | No |
| 3 | F | 75 | T6-T8 | 4 m | No | 1 |
| 4 | F | 77 | T8 | 40 m | No | 1 |
| 5 | F | 62 | T11-T12 | 1.5 m | Antiviral gabapentin | 2 |
| 6 | F | 71 | T levels | Not known | COX-2 | No |
| 7 | M | 75 | T levels | Not known | COX-2 | No |
| 8 | M | 62 | T10-T12 | 3 m | No | 1 |
| 9 | F | 82 | T levels | Not known | No | No |
| 10 | M | 63 | T8-T9 | 1 m | Antiviral | 1 |
| 11 | M | 70 | T10 | 1.5 m | Antiviral | No |